Skip to main content
Daniel Bauer, MD, Pediatric Hematology & Oncology, Boston, MA

Daniel E Bauer MD PhD

Pediatric Hematology & Oncology•Boston, MA

Pediatric Anemia and Red Blood Cell Hematology

Staff Physician, Boston Children's Hospital and Dana-Farber Cancer Institute / Associate Professor of Pediatrics, Harvard Medical School

Join to view full profile

  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-632-3000

  • Fax+1 617-632-4773

Dr. Bauer is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Bauer's full profileAlready have an account?

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2027

Publications & Presentations

PubMed

Journal Articles

  • CRISPRO: Identification of Functional Protein Coding Sequences Based on Genome Editing Dense Mutagenesis  
    Daniel Bauer, MD, BioMed Central

Abstracts/Posters

  • Durable and Robust Fetal Globin Induction without Anemia in Rhesus Monkeys Following Autologous Hematopoietic Stem Cell Transplant with BCL11A Erythroid Enhancer Editing
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AML
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Therapeutic Base Editing of Human Hematopoietic Stem Cells
    Daniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Opportunities for Scientists in Hematology: Nothing Basic About Discovery 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration
    Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA IntegrationSeptember 16th, 2026
  • Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
    Creating the World’s First CRISPR Medicine, for Sickle Cell DiseaseFebruary 20th, 2025
  • Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’
    Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’June 12th, 2017

Grant Support

  • Robust verification of genetic variant-associated candidate off-target sitesBOSTON CHILDREN'S HOSPITAL2025–2028
  • In vivo hematopoietic stem cell genetic modification by viral particlesBOSTON CHILDREN'S HOSPITAL2024–2028
  • Computational tools for precision genome editingBOSTON CHILDREN'S HOSPITAL2024–2028
  • Targeting ZNF410 for HbF reactivationBOSTON CHILDREN'S HOSPITAL2023–2027
  • Chemotherapy-free cure of hemoglobin disorders through base editingBOSTON CHILDREN'S HOSPITAL2023–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Daniel Bauer, Dr. Daniel Bauer, MD, Dr. D Bauer, Dr. Daniel E Bauer